report
cation
nanolipoplex
pulmonari
cellular
deliveri
system
smallinterf
rna
sirna
six
nanoliposom
differ
cation
lipid
formul
screen
vitro
vivo
cellular
deliveri
function
lung
cellstissu
although
six
nanoliposom
show
similar
sirna
deliveri
effici
vitro
exhibit
signific
differ
pulmonari
cellular
deliveri
function
vivo
among
variou
nanoliposom
cation
cholesterol
ecl
base
nanoliposom
show
highest
pulmonari
cellular
deliveri
vivo
lowest
cytotox
vitro
deliveri
effici
fluoresc
sirna
ecl
nanoliposom
higher
nake
sirna
vivo
treatment
myeloid
cell
leukemia
sequenc
specif
sirna
use
ecl
nanolipoplex
reduc
target
express
cell
line
wherea
control
luciferasespecif
ecl
nanolipoplex
metastat
lung
cancer
mous
model
induc
lewi
lung
carcinoma
llc
cell
intratrach
administr
ecl
nanolipoplex
significantli
silenc
mrna
protein
level
lung
tissu
reduc
format
melanoma
tumor
nodul
observ
lung
result
demonstr
util
ecl
nanoliposom
pulmonari
deliveri
therapeut
sirna
treatment
lung
cancer
potenti
respiratori
diseas
despit
initi
hope
smallinterf
rna
sirna
nextgener
therapeut
modal
progress
sirna
therapeut
clinic
trial
halt
one
biggest
challeng
progress
sirna
field
strong
depend
sirna
efficaci
effect
intracellular
deliveri
system
sinc
sirna
process
bind
specif
mrna
cytoplasm
intracellular
deliveri
sirna
prerequisit
silenc
target
gene
howev
rel
larg
size
neg
charg
sirna
make
imposs
sirna
diffus
cell
membran
extracellular
space
lung
attract
target
organ
sirnabas
therapi
intraven
administr
function
lipopolyamin
report
provid
knockdown
target
gene
lung
tissu
normal
mice
howev
upon
system
administr
sirna
may
rapidli
degrad
clear
bloodstream
lead
ineffici
deliveri
target
cell
compar
system
deliveri
direct
local
administr
sirna
via
pulmonari
rout
may
allow
higher
retent
sirna
lung
tissu
reduc
system
toxic
reflect
sever
advantag
pulmonari
deliveri
system
administr
two
four
sirna
drug
current
phase
ii
clinic
trial
deliv
intranas
inhal
despit
advanc
remain
need
develop
effect
nanocarri
sirna
direct
pulmonari
deliveri
recent
studi
report
deliveri
crucial
barrier
effect
silenc
target
gene
intratrach
administ
nake
sirna
sever
nanocarri
studi
local
lung
deliveri
sirna
exampl
poli
ester
amin
polym
use
aerosol
sirna
deliveri
mice
fatti
acidmodifi
polyethylenimin
deriv
recent
studi
intratrach
administr
sirna
mice
studi
screen
variou
cation
nanoliposom
deliveri
effici
vitro
vivo
intratrach
administr
mice
cation
nanoliposom
test
dotap
propan
dotma
edopc
cation
lipid
compon
dotap
dotma
use
previous
cation
lipid
compon
cation
liposom
nanoparticl
sirna
deliveri
exampl
dotapmodifi
cation
poli
dllactidecoglycolid
acid
nanoparticl
use
inhal
dri
powder
formul
sirna
dotapbas
cation
liposom
report
system
deliv
sirna
lung
cancer
cell
dotmabas
cation
liposom
use
increas
cellular
deliveri
first
two
author
contribut
equal
work
correspond
yu
enhanc
intrapulmonari
deliveri
anticanc
sirna
lung
cancer
therapi
use
cation
ethylphosphocholinebas
nanolipoplex
sirna
human
airway
epitheli
cell
mous
neuroblastoma
cell
vitro
compar
dotap
dotma
edopc
rel
new
cation
lipid
less
studi
carrier
nucleic
acid
therapeut
although
studi
transfect
human
umbil
vein
endotheli
cell
plasmid
dna
vivo
system
deliveri
plasmid
dna
mice
still
report
applic
edopcbas
nanoparticl
deliveri
sirna
moreov
given
high
mortal
lung
cancer
worldwid
test
efficaci
anticanc
sirna
metastas
lung
cancer
model
report
vitro
vivo
pulmonari
cellular
deliveri
function
variou
cation
nanoliposom
uncorrel
use
myeloid
cell
leukemia
sequenc
specif
sirna
anticanc
sirna
demonstr
potenti
edopcbas
cation
nanolipoplex
effect
vivo
sirna
deliveri
system
show
target
silenc
anticanc
activ
mous
metastas
lung
cancer
model
format
nanolipoplex
cation
nanoliposom
sirna
confirm
gel
retard
assay
size
measur
regardless
nanoliposom
composit
describ
tabl
retard
mobil
sirna
gel
observ
np
nitrogentophosphoru
ratio
figur
upon
complex
sirna
slight
increas
size
observ
cation
nanoliposom
tabl
extent
mean
size
increas
nanolipoplex
rel
nanoliposom
nm
regardless
cation
nanoliposom
composit
zeta
potenti
valu
nanolipoplex
mv
np
ratio
figur
howev
increas
np
ratio
substanti
enhanc
zeta
potenti
valu
compar
np
ratio
vitro
cellular
uptak
fluoresc
doublestrand
rna
dsrna
significantli
differ
among
variou
nanolipoplex
figur
nanoliposom
formul
studi
show
cellular
uptak
fluoresc
rna
similar
commerci
transfect
agent
fluorescenceactiv
cell
sort
analysi
cell
show
use
n
n
n
dimethylaminoethan
carbamoyl
cholesterol
dcchol
nanoliposom
formul
dtdl
dmdl
edl
significantli
alter
cellular
deliveri
function
fluoresc
dsrna
compar
nanoliposom
formul
use
chol
dtcl
dmcl
ecl
moreov
type
cation
lipid
ie
dotap
dtcl
dotma
dmcl
edopc
ecl
significantli
affect
vitro
cellular
uptak
fluoresc
dsrna
vivo
pulmonari
cellular
uptak
fluoresc
dsrna
cation
nanolipoplex
unlik
vitro
intracellular
deliveri
vivo
pulmonari
cellular
uptak
fluoresc
dsrna
significantli
depend
lipid
composit
nanolipoplex
figur
among
dccholbas
nanoliposom
edl
yield
higher
mean
valu
fluorescentposit
cell
popul
compar
dtdl
dmdl
howev
signific
differ
among
dccholbas
cation
nanoliposom
fluoresc
dsrna
deliveri
function
vivo
contrast
cholbas
cation
nanoliposom
show
distinct
differ
vivo
pulmonari
cellular
deliveri
function
fluoresc
dsrna
depend
cation
lipid
use
nanolipoplex
use
edopc
ecl
produc
higher
level
pulmonari
cellular
uptak
fluoresc
dsrna
compar
dotap
dtcl
dotma
dmcl
respect
fluoresc
dsrna
complex
ecl
produc
higher
vivo
deliveri
nake
form
repres
flow
cytometri
data
present
figur
although
figur
show
significantli
higher
pulmonari
cellular
uptak
fluoresc
dsrna
ecl
nanolipoplex
rel
free
form
imag
lung
tissu
includ
extracellular
space
reveal
signific
differ
figur
molecular
imag
analys
whole
lung
show
similar
increas
fluoresc
intens
group
treat
fluoresc
dsrna
free
ecl
nanolipoplex
compar
untreat
control
group
figur
although
vitro
cellular
deliveri
fluoresc
dsrna
significantli
differ
among
cation
nanoliposom
formul
cytotox
highli
affect
composit
cation
nanoliposom
figur
cytotox
luciferasespecif
complex
variou
nanoliposom
measur
cell
day
cytotox
nanolipoplex
similar
complex
day
treatment
viabil
cell
treat
nanolipoplex
compar
cell
among
nanolipoplex
prepar
studi
nanolipoplex
least
effect
cell
viabil
follow
nanolipoplex
compar
cell
treat
nanolipoplex
treat
nanolipoplex
show
higher
viabil
hour
treatment
sinc
nanolipoplex
exhibit
lowest
cytotox
figur
test
vitro
target
gene
reduct
capabl
sirna
use
ecl
nanoliposom
function
sirna
complex
ecl
nanoliposom
comparison
luciferasespecif
complex
ecl
nanoliposom
gel
electrophoresi
revers
transcriptionpcr
rtpcr
product
figur
reveal
mrna
level
reduc
treatment
cell
ecl
nanolipoplex
lipoplex
howev
decreas
mrna
observ
treatment
cell
complex
ecl
nanoliposom
realtim
rtpcr
use
quantifi
extent
mrna
downregul
treatment
ecl
nanolipoplex
figur
mrna
express
level
follow
treatment
cell
nonfunct
ecl
nanolipoplex
respect
contrast
follow
treatment
cell
nanolipoplex
mrna
express
level
reduc
observ
group
treat
nanolipoplex
p
intratrach
administr
ecl
nanolipoplex
inhibit
growth
lewi
lung
carcinoma
llc
cell
lung
tissu
intraven
inject
llc
day
sirna
nake
ecl
complex
intratrach
inject
day
figur
lung
tissu
extract
day
evalu
metastasi
growth
intraven
administ
llc
mice
inject
treat
sirna
use
control
black
coloni
metastas
observ
lung
tissu
untreat
group
figur
group
treat
free
figur
nanolipoplex
figur
nanolipoplex
figur
howev
extent
blackish
tumor
nodul
lowest
group
treat
nanolipoplex
figur
silenc
lung
tissu
observ
mrna
protein
level
deliveri
ecl
nanolipoplex
figur
quantit
realtim
rtpcr
data
figur
reveal
rel
mrna
express
level
normal
dehydrogenas
gapdh
reduc
llcbear
lung
tissu
respect
intratrach
treatment
mice
ecl
nanolipoplex
compar
mice
treat
nanolipoplex
p
similar
mrna
express
level
protein
express
lung
tissu
reduc
upon
intratrach
administr
nanolipoplex
lung
cancer
anim
model
induc
figur
llc
figur
western
blot
analys
show
notabl
silenc
protein
express
nanolipoplextr
group
group
differ
actin
protein
level
among
group
studi
demonstr
vitro
sirna
deliveri
effici
close
correspond
vivo
pulmonari
sirna
deliveri
effici
moreov
show
vivo
effici
sirna
deliveri
pulmonari
cell
significantli
affect
type
cation
lipid
colipid
use
ecl
nanolipoplex
provid
highest
vivo
sirna
deliveri
effici
importantli
intratrach
administr
nanolipoplex
silenc
mrna
protein
level
inhibit
growth
metastas
lung
cancer
mice
addit
cation
lipid
cation
nanoliposom
describ
prepar
use
dope
dcchol
chol
colipid
nanoliposom
contain
dope
fusogen
lipid
compon
regardless
whether
dcchol
chol
use
exploit
fusogen
function
research
use
dope
helper
lipid
liposom
base
dotap
dotma
dcchol
deriv
chol
differ
structur
chol
contain
cation
moieti
recent
studi
report
use
dcchol
dopebas
cation
liposom
deliveri
plasmid
dna
sirna
compar
analysi
reveal
substanti
discrep
vitro
vivo
cellular
uptak
although
fluoresc
figur
howev
enhanc
transfect
human
umbil
vein
endotheli
cell
previous
observ
plasmid
dna
edopcbas
moreov
edopc
known
serum
compat
enhanc
transfect
efficaci
plasmid
dna
regardless
presenc
serum
given
previou
find
possibl
ecl
might
stabil
nanolipoplex
bloodstream
due
serum
compat
confer
increas
bind
surfac
pulmonari
endotheli
cell
therebi
facilit
uptak
complex
sirna
cell
addit
lack
correl
vitro
vivo
fluoresc
dsrna
deliveri
effici
lack
correl
pulmonari
cellular
deliveri
effici
figur
whole
lung
tissu
deliveri
determin
molecular
imag
figur
fluoresc
dsrna
use
model
evalu
cellular
uptak
variou
sirna
nanocarri
although
observ
increas
fluoresc
dsrna
deliveri
ecl
nanolipoplex
compar
nake
form
differ
fluoresc
intens
whole
lung
tissu
imag
discrep
vivo
cellular
level
whole
tissu
level
data
might
reflect
presenc
nake
fluoresc
dsrna
extracellular
space
lung
tissu
yield
fluoresc
signal
molecular
imag
compar
nanolipoplex
fluoresc
dsrna
insid
pulmonari
cell
result
emphas
import
measur
cellular
uptak
level
sirna
vivo
evalu
nanocarri
addit
molecular
imag
whole
tissu
entir
bodi
vivo
tumor
distribut
polymer
micel
without
folat
ligand
modif
also
investig
tumor
tissu
tumor
cell
level
previou
studi
tumor
tissu
distribut
polymer
micel
found
similar
regardless
folat
ligand
modif
despit
similar
distribut
whole
tissu
level
polymer
micel
folat
ligand
taken
cell
wherea
plain
polymer
micel
found
extracellular
space
studi
provid
addit
support
interpret
discrep
whole
tissu
distribut
target
celllevel
uptak
present
ecl
nanolipoplex
show
highest
vivo
pulmonari
cellular
deliveri
fluoresc
dsrna
also
exhibit
lowest
cytotox
cell
figur
aim
compar
cytotox
cation
nanoliposom
per
se
sirna
thu
use
nanolipoplex
form
nonfunct
luciferas
sirna
rather
cytotox
cytotox
cation
nanocarri
report
reflect
interact
cation
compon
mitochondri
membran
activ
caspas
pathway
induct
mitochondri
mediat
apoptosi
depend
cytotox
cation
lipid
might
explain
part
degrad
kinet
lipid
endosom
environ
toxic
cellular
degrad
product
unlik
chemic
synthes
cation
lipid
dota
dotap
edopc
deriv
natur
lipid
phosphatidylcholin
simpl
modif
structur
similar
natur
phosphatidylcholin
edopc
consid
readili
metaboliz
bodi
report
edopc
readili
hydrolyz
phospholipas
metabol
halflif
day
cell
moreov
greater
viabil
cell
treat
ecl
rel
treat
edl
figur
may
explain
addit
presenc
cation
lipid
dcchol
edl
rather
natur
chol
present
ecl
anticanc
sirna
complex
ecl
nanoliposom
vivo
treatment
lung
cancer
vivo
studi
compar
anticanc
activ
free
ecl
nanolipoplex
complex
commerci
suppli
vitro
transfect
nucleic
acid
cell
cultur
vivo
experi
need
complex
sirna
suffici
intratrach
administr
dose
mg
kg
howev
current
suppli
concentr
could
form
nanolipoplex
sirna
concentr
vivo
inject
report
antiapoptot
protein
involv
prolifer
surviv
lung
cancer
cell
moreov
overexpress
found
lung
cancer
tissu
thu
silenc
protein
predict
promot
apoptosi
cancer
cell
consist
recent
report
enhanc
apoptosi
variou
solid
tumor
cell
includ
lung
cancer
cell
addit
intratumor
treatment
complex
tocopherol
deriv
oligochitosanbas
nanoparticl
shown
inhibit
growth
kb
tumor
xenograft
mice
final
codeliveri
histon
deacetylas
inhibitor
use
cation
nanoliposom
demonstr
provid
synergist
anticanc
activ
intraven
administr
use
lung
metastasi
intraven
inject
cell
mice
lung
cancer
model
found
intratrach
administr
nanolipoplex
reduc
format
tumor
nodul
lung
tissu
previou
studi
use
approach
establish
vivo
lung
metastasi
anim
model
lung
cancer
model
signific
advantag
orthotop
diseas
model
may
mimic
pathogenesi
metastat
lung
cancer
human
intratrach
nebul
microspray
use
lung
deliveri
administr
method
may
close
mimic
clinic
suitabl
aerosol
dosag
form
intranas
rout
format
tumor
nodul
lowest
nanocomplextr
group
consist
highest
uptak
pulmonari
cell
vivo
figur
silenc
antiapoptot
lung
tissu
mrna
protein
level
group
previous
sirna
sar
coronaviru
intratrach
administ
rhesu
macaqu
latter
studi
sirna
deliv
nake
form
use
glucos
distil
water
carrier
solut
recent
report
uptak
efficaci
nake
sirna
via
intratrach
administr
mice
suggest
deliveri
remain
key
obstacl
efficaci
topic
administ
nake
oligonucleotid
lung
support
import
effect
deliveri
system
local
deliveri
sirna
sever
possibl
may
exist
explain
highest
sirna
deliveri
effici
ecl
nanolipoplex
lung
tissu
one
possibl
enhanc
serum
stabil
ecl
compar
cation
liposom
edopc
cation
deriv
dioleyoylphosphatidylcholin
structur
similar
natur
membran
lipid
compon
phosphatidylcholin
edopc
known
phase
transit
temperatur
similar
natur
phosphatidylcholin
quit
insensit
ionic
strength
low
sensit
edopc
ionic
strength
biolog
environ
may
confer
stabil
ecl
vivo
contribut
higher
interact
lung
epitheli
cell
previous
serum
stabil
edopcbas
lipoplex
plasmid
dna
report
studi
incub
edopc
plasmid
dna
complex
nearli
pure
serum
reduc
transfect
effici
previou
studi
support
high
vivo
effici
ecl
might
contribut
part
serum
stabil
edopc
moreov
exclud
possibl
edopc
may
enhanc
interact
lung
cell
intratrach
administr
biodistribut
studi
mice
follow
intraven
administr
plasmid
dna
edopcbas
nanoparticl
reveal
discret
express
plasmid
dna
lung
tissu
result
suggest
import
cation
lipid
colipid
select
vivo
sirna
deliveri
effect
cation
lipid
structur
sirna
transfect
effici
previous
report
head
group
cation
lipid
shown
influenc
vivo
sirna
deliveri
effici
small
molecular
dissimilar
ioniz
cation
lipid
result
signific
differ
genesilenc
potenc
sirna
mous
head
group
affect
pka
valu
cation
lipid
may
modul
extent
posit
charg
physiolog
ph
consequ
influenc
adsorpt
plasma
protein
biodistribut
behavior
moreov
extent
unsatur
hydrocarbon
chain
cation
lipid
may
affect
sirna
deliveri
effici
high
degre
unsatur
bond
hydrocarbon
chain
cation
lipid
known
facilit
sirna
deliveri
addit
cation
lipid
colipid
report
play
import
role
sirna
deliveri
effici
among
variou
colipid
dope
wide
use
colipid
cation
liposomemedi
transfecton
sirna
plasmid
dna
role
dope
fulli
understood
recent
studi
report
dope
might
affect
structur
transit
cation
liposom
acid
ph
late
endosom
cell
moreov
dope
cation
liposom
report
induc
format
hexagon
phase
facilit
releas
nucleic
acid
complex
endosom
although
use
dope
colipid
studi
inclus
polyunsatur
fatti
acid
linol
acid
linolen
acid
lipid
nanoparticl
shown
enhanc
vivo
genesilenc
effici
studi
specif
demonstr
anticanc
therapeut
effect
ecl
nanolipoplex
lung
tumor
model
effect
pulmonari
cellular
deliveri
effici
sirna
vivo
silenc
target
protein
lung
tissu
suggest
util
ecl
nanoliposom
inhal
dosag
form
sirna
nucleic
acid
therapeut
anticip
inhal
sirna
appli
variou
lung
diseas
includ
cystic
fibrosi
inflammatori
condit
infecti
diseas
cancer
ecl
nanoliposom
provid
mean
deliv
pathogen
proteinspecif
sirna
lung
cell
aerosol
dosag
form
offer
approach
target
malign
protein
whose
overexpress
contribut
patholog
variou
lung
diseas
conclus
result
suggest
import
vivo
screen
evalu
sirna
nanocarri
vivo
cellular
level
uptak
studi
differenti
extracellular
intracellular
deliveri
nanocarri
moreov
ecl
nanolipoplex
might
appli
futur
intrapulmonari
deliveri
sirna
treat
variou
lung
diseas
caus
overexpress
pathogen
protein
prepar
cation
nanoliposom
cation
nanoliposom
prepar
use
lipidfilm
hydrat
method
previous
describ
chol
purchas
sigmaaldrich
st
loui
mo
lipid
edopc
dotap
dotma
dcchol
dope
obtain
avanti
polar
lipid
birmingham
al
usa
lipid
dissolv
chloroform
mix
differ
composit
evapor
use
rotari
evapor
elimin
organ
solvent
nanoliposom
prepar
edopc
chol
dope
total
lipid
mix
molar
ratio
tabl
nanoliposom
formul
dotap
dotma
use
instead
edopc
dcchol
use
place
chol
thin
lipid
film
hydrat
ml
mmoll
hepe
ph
result
nanoliposom
extrud
three
time
polycarbon
membran
filter
isopor
millipor
billerica
use
extrud
northern
lipid
vancouv
british
columbia
canada
complex
variou
cation
nanoliposom
sirna
size
zeta
potenti
nanolipoplex
determin
use
instrument
photal
osaka
japan
cell
cultur
sirna
uptak
murin
melanoma
cell
line
murin
llc
cell
purchas
american
type
cultur
collect
manassa
va
cell
maintain
dulbecco
modifi
eagl
medium
humidifi
co
atmospher
media
enrich
fetal
bovin
serum
hyclon
logan
ut
penicillin
streptomycin
sigmaaldrich
cellular
uptak
sirna
determin
cell
seed
onto
plate
day
treatment
replac
medium
fresh
well
fluoresc
label
dsrna
blockit
invitrogen
carlsbad
ca
concentr
nmoll
mix
nanoliposom
np
ratio
lipofectamin
invitrogen
accord
manufactur
instruct
result
nanolipoplex
ad
cell
incub
hour
cell
harvest
wash
three
time
phosphatebuff
salin
pb
evalu
flow
cytometri
use
bd
facscalibur
system
cell
quest
pro
analysi
softwar
bd
bioscienc
san
jose
ca
cytotox
assay
cytotox
cation
nanoliposom
monitor
use
tetrazolium
bromid
mtt
assay
cell
seed
onto
plate
densiti
cellswel
allow
attach
day
medium
replac
fresh
cultur
medium
luciferasespecif
sirna
st
pharm
seoul
korea
nonfunct
mammal
complex
variou
cation
nanoliposom
np
ratio
accord
manufactur
instruct
nanolipoplex
ad
cell
concentr
nmoll
incub
variou
time
period
cell
treat
mgml
mtt
solut
hour
untreat
cell
use
control
cultur
medium
remov
n
hclisopropanol
solut
ad
viabil
cell
measur
wavelength
nm
use
micropl
reader
sunris
tecan
switzerland
viabil
cell
group
express
rel
untreat
cell
percentag
knockdown
mrna
sirna
evalu
rtpcr
quantit
realtim
rtpcr
vitro
knockdown
studi
concentr
nmoll
complex
ecl
nanoliposom
np
ratio
result
nanolipoplex
appli
cell
seed
onto
plate
hour
total
rna
isol
use
trizol
reagent
invitrogen
revers
transcrib
cdna
use
accupow
rt
premix
bioneer
daejeon
korea
vivo
knockdown
studi
free
sirna
sirna
complex
ecl
nanolipoplex
intratrach
administ
see
total
rna
isol
collect
lung
tissu
revers
transcrib
cdna
primer
murin
sens
ctttgttt
antisens
rtpcr
product
electrophores
agaros
gel
visual
ethidium
bromid
stain
quantit
realtim
rtpcr
perform
glass
capillari
use
lightcycl
instrument
lightcycl
faststart
dna
master
plu
sybr
green
reagent
data
analyz
use
lightcycl
softwar
program
roch
diagnost
mannheim
germani
thermocycl
paramet
consist
hot
start
minut
follow
cycl
second
second
second
melt
curv
analysi
perform
confirm
specif
pcr
product
amplif
step
level
mrna
express
normal
housekeep
gene
gapdh
vivo
uptak
sirna
lung
tissu
test
flow
cytometri
molecular
imag
six
week
old
femal
balbc
mice
purchas
daehan
biolink
seungnam
korea
anim
maintain
use
accord
guidelin
care
use
laboratori
anim
institut
laboratori
anim
resourc
seoul
nation
univers
sirna
deliveri
effici
variou
nanoliposom
monitor
administ
nanoliposom
complex
blockit
sirna
np
ratio
via
intratrach
rout
hour
mice
kill
lung
tissu
sampl
collect
homogen
ml
pb
use
pore
diamet
cell
strainer
spl
life
scienc
pochon
korea
follow
centrifug
minut
pellet
suspend
incub
room
temperatur
minut
ml
red
blood
cell
lysi
buffer
moll
nh
cl
mmoll
ethylenediaminetetraacet
acid
centrifug
minut
wash
three
time
pb
suspend
cell
analyz
use
flow
cytometri
molecular
imag
extract
lung
tissu
evalu
la
imag
analyz
fujifilm
tokyo
japan
fluoresc
intens
analyz
use
imag
gaug
analyz
softwar
fujifilm
vivo
tumor
model
prepar
inject
femal
balbc
mice
murin
lung
carcinoma
llc
cell
pb
via
tail
vein
sirna
specif
silenc
purchas
bioneer
five
day
inocul
mice
given
initi
intratrach
inject
nanocomplex
dose
mg
kg
use
microspray
penncenturi
wyndmoor
pa
mice
administ
nanolipoplex
four
time
everi
day
kill
day
lung
tissu
sampl
collect
prepar
cell
suspens
describ
vivo
silenc
target
mrna
protein
analyz
use
quantit
realtim
rtpcr
describ
western
blot
analysi
respect
vivo
silenc
target
protein
express
simcl
evalu
western
blot
previous
describ
rna
interfer
effect
protein
level
evalu
first
homogen
extract
lung
tissu
cell
lysi
buffer
triton
mmoll
ethylenediaminetetraacet
acid
moll
trishcl
follow
centrifug
minut
extract
total
protein
quantifi
use
bca
protein
assay
kit
thermo
fisher
scientif
rockford
il
accord
manufactur
instruct
separ
sdspage
polyacrylamid
gel
transfer
protein
onto
polyvinyliden
difluorid
membran
western
blot
perform
use
specif
antibodi
abcam
cambridg
uk
actin
santa
cruz
biotechnolog
santa
cruz
ca
band
visual
use
alkalin
phosphataseconjug
antiigg
antibodi
santa
cruz
biotechnolog
statist
analysi
varianc
use
analyz
experiment
data
applic
post
hoc
studentnewmankeul
test
pairwis
comparison
statist
analys
done
use
sigmastat
softwar
version
systat
softwar
richmond
ca
p
valu
consid
signific
